Back to Search
DOUGLAS SHEMIN, MD
MD
Nephrology Physician
NPI: 1710934724IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
MD06411(RI)
Education
STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Research & Publications (16)
Residual renal function and mortality risk in hemodialysis patients.
PMID 11431186·Am J Kidney Dis·2001
8-other
Treatment of hyperhomocysteinemia in end-stage renal disease.
PMID 11576930·Am J Kidney Dis·2001
6-review
Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
PMID 17722046·J Clin Apher·2007
4-observational
The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.
PMID 12552508·Am J Kidney Dis·2003
3-trial
A multicenter, prospective, randomized, comparative evaluation of dual- versus triple-lumen catheters for hemodialysis and apheresis in 485 patients.
PMID 12900814·Am J Kidney Dis·2003
3-trial
Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
PMID 12637653·Nephrol Dial Transplant·2003
4-observational
Prevalence of protein malnutrition in children maintained on peritoneal dialysis.
PMID 12172768·Pediatr Nephrol·2002
8-other
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
PMID 12427152·Kidney Int·2002
3-trial
Clinical morbidity in pediatric dialysis patients: data from the Network 1 Clinical Indicators Project.
PMID 11685588·Pediatr Nephrol·2001
8-other
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
PMID 11169020·Kidney Int Suppl·2001
3-trial
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
PMID 11135086·Kidney Int·2001
3-trial
First hemodialysis access selection varies with patient acuity.
PMID 11053581·Adv Ren Replace Ther·2000
8-other
Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project.
PMID 10922309·Am J Kidney Dis·2000
8-other
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
PMID 10859289·Circulation·2000
3-trial
Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.
PMID 10852611·Transplantation·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 375 WAMPANOAG TRL
RIVERSIDE, RI 02915 - Phone
- (404) 649-4060
Quick Facts
- NPI
- 1710934724
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Publications
- 16
Are you this provider?
Claim Your Profile